| 摘要 |
<p>A combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD), for use in the treatment of cancer, in particular a brain tumour, more specifically a glioma/glioblastoma. Preferably the compounds are in the ratio of 5:1 to 1:5. Preferably the cannabinoids are present as plant extracts. They may be administered separately, sequentially or simultaneously.</p> |
